Sapna Palla
Partner
New York

Sapna Palla
Partner
New York
Contact details
Sapna is a partner in the firm’s Intellectual Property Litigation Department. She has spent over two decades representing clients in patent, trademark, copyright, trade secrets and complex commercial matters, including successfully litigating disputes in a range of jurisdictions. She also has extensive experience with alternative dispute resolution, including arbitration and mediation.
Sapna also counsels and represents a variety of U.S. and international clients regarding U.S. intellectual property by providing them with infringement, validity, enforceability, and clearance opinions and by advising them in licensing and antitrust matters. She has also conducted intellectual property due diligence investigations in connection with acquisitions and licensing deals. Sapna also counsels clients about patent law in Asia, including China and India.
Sapna’s patent experience covers a broad array of technologies, including pharmaceuticals, biotechnology, medical devices, drug delivery systems, software, mechanical devices, batteries, and agrochemicals. Outside the patent area, she has represented clients in trademark, trade dress, and copyright litigation as well as in counseling clients on trademark and copyright registration, strategy, and licensing. Sapna has also handled a number of complex commercial disputes involving complex contractual matters in the oil, renewable energy, construction, and food services industries.
Sapna was selected by the New York City Bar Association as their 2021 Diversity & Inclusion Champion Award winner for her commitment to diversity, equity and inclusion. She has been honored by the City and State of New York (NY) as “one of the most influential Asian Americans in New York politics and policy” in 2020. She frequently writes and speaks on a range of topics, including developments in litigation, e-discovery, patent law, patent reform, intellectual property law in Asia, pharmaceuticals, biosimilars, biotechnology, and medical devices. Her programs have been presented by the Practicing Law Institute and WestLegal Ed, and she has been published and quoted in leading publications, including Practicing Law Institute, Forbes, ABA Litigation Journal, IP Law360, New York Law Journal, Corporate Counsel Connect, Pharmaceutical Patent Analyst, and Bloomberg/BNA.
She is an adjunct professor at Pace University School of Law, addressing antitrust and patent topics. She clerked for the Honorable Judge Robert J. Hurley of the U.S. District Court for the Eastern District of New York.
Sapna is Immediate Past President of the Asian American Bar Association of New York (AABANY) and the co-founder of the AABANY Leadership Development Institute. She was previously on the Board of Directors at AABANY and served as co-chair of the Women’s Committee. Sapna is co chair of the Patent Litigation Committee of the American Bar Association. She is an inaugural member of Judge Janet Bond Arterton’s Intellectual Property American Inns of Court and is a member of the New York Intellectual Property Association and its Litigation and Legislative Action Committees.
Sapna is committed to pro bono legal services. In 2008, she was honored by the Pennsylvania Capital Representative Project for extraordinary efforts on behalf of Pennsylvania’s death row inmates. In 2001, she received the Legal Aid Society award for Outstanding Pro Bono Representation.
Sapna has lived and studied in both India and Tanzania. She is fluent in Hindi and Marathi and conversant in French.
Qualifications
Professional
Admitted: US Court of Appeals for the Federal Circuit, 2006
Admitted: US District Court (Southern District of New York), 2005
Admitted: Bar of the State of New York, 2001
Academic
J.D., summa cum laude, Pace University School of Law, 1998
B.B.A., magna cum laude, Pace University, 1995
Related articles

News: 18 October 2023
LMG Life Sciences 2023 recognizes three A&O partners
The following partners have been recognized as Life Sciences Stars, in various practice areas:
Blog Post: 05 October 2023
Blog Post: 22 September 2023

Qualifications
Professional
Admitted: US Court of Appeals for the Federal Circuit, 2006
Admitted: US District Court (Southern District of New York), 2005
Admitted: Bar of the State of New York, 2001
Academic
J.D., summa cum laude, Pace University School of Law, 1998
B.B.A., magna cum laude, Pace University, 1995
Published work
- Author, “The Patent Eligibility Battle for Life Sciences Companies in a Changing Landscape,” The National Law Review, July 11, 2018
- Co-author, “Legal Issues for High-Growth Technology Companies,” The National Law Review, May 2, 2018
- Co-author, “How to Shift Your Litigation Strategies for the New IP Landscape,” The National Law Journal, July 17, 2017
- Co-author, “Global IP Trends: A Guide to Recent International Considerations for Patent Rights,” September 1, 2016
- Co-author, “The New Biosimilars Frontier,” January 26, 2016
- Co-author, “Devising a Patent Strategy to Protect The Intellectual Property of Biologics in Light of Ambiguities, Loopholes, and Pitfalls in The Regulatory Scheme,” Pharm Pat. Analyst, March 2013
- Co-author, “Best Mode, Chapter for Pharmaceutical and Biotech Patent Law,” Practicing Law Institute, November 1, 2012
- Author, “Patent Invalidity Rates in China,” White Paper, Intellectual Property Organization, September 1, 2012
- Author, “Patent Invalidity Rates in Japan,” White Paper, Intellectual Property Organization, September 1, 2012
- Author, “Should the Federal Circuit’s Model E-Discovery Order Change the Way [You] Conduct E-Discovery for Patent Litigation?” Bloomberg Law, January 23, 2012
- Author, “Understanding the voluntary Carbon Market: Why Companies Buy Carbon Credits, Why the Voluntary Market Will Coexist with Future Mandatory Regulation, and Why Contracts Should Allocate Carbon Credit Ownership,” Bloomberg Law Reports – Sustainable Energy, May 1, 2009
Awards & accolades
Leading Life Sciences Lawyer
LMG Life Sciences, 2022
IAM Patent 1000
2022